Faruqi & Faruqi, LLP Launches An Investigation Against Synergetics USA, Inc. (SURG) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc. (“Synergetics” or the “Company”) (NasdaqCM: SURG) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval for the Second Amended and Restated Synergetics USA, Inc. 2001 Stock and Performance Incentive Plan.
Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on November 12, 2013, the Board of Directors recommends that Synergetics’ shareholders vote to approve the Second Amended and Restated Synergetics USA, Inc. 2001 Stock and Performance Incentive Plan to increase the number of shares available for issuance thereunder from 1,345,000 to 2,000,000. The issuance of the additional shares could have a substantial dilutive effect on the shares of Synergetics common stock.
If you own common stock in Synergetics and wish to obtain additional information and protect your investments free of charge, please contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.